Different State Regulatory Approaches Reflect Open Questions About AI Mental Health Tools — The Monitor
States are taking different regulatory approaches to AI mental health tools in response to concerns…
States are taking different regulatory approaches to AI mental health tools in response to concerns about chatbots providing inaccurate or potentially dangerous advice. Laws and pending legislation in some states restrict AI from providing or advertising itself as therapy, while others focus on data protections, disclosures, and patient consent requirements.
Consumer drug platforms and how they fit into the rise of the consumer in healthcare will be part of the conversation at INVEST Digital Health, scheduled for October 29 in Dallas. Register today! The post What Do the Latest Iteration of Consumer Drug Platforms Offer? appeared first on MedCity News.
The KFF Health News Minute is available every Thursday via direct download or the RSS feed. Aug. 27 Katheryn Houghton [CATH-er-in HOW-tun] reads the week’s news: A wristband with the words “I Gave Birth” could be a lifesaving tool for new moms, and many homeless people will have to prove they’re working to stay on Medicaid. Your browser does not support the audio element. Can’t see the audio player?…
One year into its creation, a $50 billion federal program aimed at improving rural healthcare lacks transparency, which could make it difficult to protect against fraud, identify successful projects, and ensure the program delivers on its promise to transform the system. Transparency “is really important to help protect the integrity of the program, ensure funds…
KFF Health News worked with three Louisiana news outlets — The Current, Gulf States Newsroom, and Verite News — to ask all 64 sheriffs in the state how they’ve spent their opioid settlement funds. The responses were shared and presented in a data table for all four newsrooms to use. Reporters then conducted individual reporting…
MILLVILLE, Pa. — In an open field, arrows whizzed through the humid June air and struck their targets. Campers and counselors cheered. It was archery hour at Camp Cranium. Operations director Drew Meyer watched, a few tears escaping from behind his dark sunglasses. “They will surprise you, like, flat out,” he said of the campers,…
Onos Health’s Series A funding round was led by Costanoa, with support from Flare Capital Partners and CVS Health Ventures. The post Onos Health Raises $17M to Expand AI-Powered Behavioral Health Platform appeared first on MedCity News.
This data note presents key data points describing the current state of the Medicaid program as it affects women.
Boston Scientific disclosed a cyberattack disrupting its global IT systems and order shipping capabilities, with the company unable to provide a timeline for when normal operations will resume. The disclosure adds the medical device giant to a growing list of medtech companies — including Stryker, Medtronic and Abbott — hit by major cyberattacks this year….
FDA approval of Revolution Medicines’ daraxonrasib, brand name Rasonque, makes the molecule the first RAS inhibitor approved for treating pancreatic adenocarcinoma, the most common type of pancreatic cancer. The speedy regulatory nod specifically covers advanced cases of this type of cancer, which has had limited treatment options. The post Revolution Medicines Receives Landmark FDA Drug…